| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.26 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |